Alnylam Beats Acuitas Claim on Patents in Pfizer Shot Suit (1)

A federal judge dismissed Acuitas Therapeutics Inc.'s lawsuit seeking to name its scientists as inventors on seven Alnylam Pharmaceuticals Inc. patents tied to Covid-19 vaccine technology, blunting its effort to derail Alnylam’s case against Pfizer Inc. and BioNTech SE.

Acuitas and its scientists failed to show any “concrete” financial or reputational harm, Chief Judge Colm F. Connolly wrote in an opinion issued Tuesday in the US District Court for the District of Delaware. He called their allegations “conclusory” and said the complaint didn’t “plausibly imply” a personal stake in the outcome, falling short of what’s required to invoke federal ...